Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Aeterna is stocked at 34 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Buffalo, Hudson, and Queens. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Aeterna's mix in October 2026 concentrated into Flower at 61.86% share with year-over-year decline of 74.34% and month-over-month decline of 34.36%, while Pre-Roll held 25.25% share with year-over-year decline of 62.67% and month-over-month decline of 36.63%. The outlier was Concentrates at 12.89% share with year-over-year growth of 189.63% and month-over-month growth of 40.33%, against a brand-level year-over-year sales decline of 68.07%. With average price up 6.95% and category average prices diverging (Flower at 44.67 vs Concentrates at 32.05), the pattern indicates a pivot: rapid unit and revenue momentum in Concentrates is offsetting steep contractions in Flower and Pre-Roll, implying a deliberate shift toward higher-velocity sublines despite the brand’s overall 61.22% decline over 24 months.
The mix shift implies Aeterna is repositioning away from legacy Flower and Pre-Roll reliance toward a differentiated Concentrates foothold, where a 12.89% share now anchors relative stability as Flower erodes by 74.34% year over year and Pre-Roll by 62.67% year over year. Given a 40.33% month-over-month gain in Concentrates alongside a 36.63% month-over-month drop in Pre-Roll, the near-term trajectory suggests reallocation benefits when assortment and pricing steer toward Concentrates’ elasticity at an average price of $32.05. With Concentrates ranked 47 in New York and Flower down 34.36% month over month, the implication is that deeper emphasis on Concentrates can stabilize rank and share as the brand trims exposure to categories where price points (e.g., Flower at $44.67) constrain demand.
Competitive Landscape
Aeterna ranks #47 in New York Concentrates in October 2026, down 3 positions year over year from #44 and 10 positions from July 2026’s #37, while also sitting 16 places below its June 2026 peak at #31; by contrast, UMAMII surged from #17 to #2 and RYTHM inched up from #4 to #3 as Jetpacks slipped from #2 to #4 with a -22.9% year-over-year sales change. The combination of Aeterna’s rank decline of 3 places year over year and 10 places since July 2026, alongside competitor gains like UMAMII’s 15-rank climb and RYTHM’s 1-rank rise, implies Aeterna is losing relative velocity in a tier where upward mobility is concentrated among a few fast-advancing peers.
Notable Products
Aeterna’s October 2026 lineup is concentrated, with the top 10 items accounting for 62.0% of sales and the leading product, Gelato 33 Infused Pre-Roll 5-Pack (2.5g), alone at 12.9%. That level of concentration means most of its sales come from a relatively small slice of the catalog.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






